Impact of Maintenance Therapy in High-Risk Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation

被引：0
|
作者：
Bashir, Qaiser [1 ]
Milton, Denai [2 ]
Popat, Uday R. [2 ]
Oran, Betul [2 ]
Nieto, Yago [1 ]
Kebriaei, Partow [1 ]
Ciurea, Stefan O. [2 ]
Ahmed, Sairah [2 ]
Mehta, Rohtesh S. [2 ]
Olson, Amanda [2 ]
Parmar, Simrit [2 ]
Alatrash, Gheath [3 ]
Hosing, Chitra M. [1 ]
Shah, Nina [4 ]
Patel, Krina [3 ]
Weber, Donna [1 ]
Thomas, Sheeba [1 ]
Manasanch, Elisabet [3 ]
Lee, Hans C. [3 ]
Orlowski, Robert Z. [1 ]
Champlin, Richard E. [2 ]
Qazilbash, Muzaffar H. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Lymphoma Myeloma, Houston, TX 77030 USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2018年 / 24卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
332
引用
收藏
页码：S243 / S244
页数：2
相关论文
共 50 条
  • [1] Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma
    Green, Damian J.
    Maloney, David G.
    Storer, Barry E.
    Sandmaier, Brenda M.
    Holmberg, Leona A.
    Becker, Pamela S.
    Fang, Min
    Martin, Paul J.
    Georges, George E.
    Bouvier, Michelle E.
    Storb, Rainer
    Mielcarek, Marco
    [J]. BLOOD ADVANCES, 2017, 1 (24) : 2247 - 2256
  • [2] Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple Myeloma
    Pasvolsky, Oren
    Milton, Denai R.
    Rauf, Mikael
    Tanner, Mark R.
    Bashir, Qaiser
    Srour, Samer
    Tang, Guilin
    Saini, Neeraj
    Ramdial, Jeremy
    Masood, Adeel
    Nieto, Yago
    Lee, Hans C.
    Patel, Krina K.
    Kebriaei, Partow
    Thomas, Sheeba K.
    Weber, Donna M.
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (11): : 752.e1 - 752.e6
  • [3] Part I: The Role of Maintenance Therapy in Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation
    McCarthy, Philip L.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (01): : 35 - 42
  • [4] Panobinostat As a Maintenance Therapy after Autologous Hematopoietic Cell Transplantation for Patients with Multiple Myeloma
    Nishihori, Taiga
    Baz, Rachid
    Ochoa, Leonel
    Puglianini, Omar Alexis Castaneda
    Shain, Kenneth H.
    Brayer, Jason B.
    Locke, Frederick L.
    Kim, Jongphil
    Song, Jinming
    Dumala, Michael
    Alsina, Melissa
    [J]. BLOOD, 2019, 134
  • [5] Autologous hematopoietic cell transplantation for high-risk ALL
    Linker, C.
    Damon, L.
    Martin, T.
    Blume, K.
    Forman, S.
    Snyder, D.
    Wolf, J.
    Negrin, R.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 (03) : 460 - 461
  • [6] Impact of Non High-Risk Chromosomal Abnormalities on the Outcome of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Ahmed, Sairah
    Lin, Heather
    Baladandayuthapani, Veera
    Khan, Mubeen A.
    Lu, Gary
    Rondon, Gabriela
    Qureshi, Sofia
    Dinh, Yvonne T.
    Bashir, Qaiser
    Shah, Nina
    Parmar, Simrit
    Hosing, Chitra M.
    Popat, Uday
    Giralt, Sergio A.
    Orlowski, Robert Z.
    Shah, Jatin J.
    Champlin, Richard
    Qazilbash, Muzaffar H.
    [J]. BLOOD, 2011, 118 (21) : 156 - 157
  • [7] Autologous hematopoietic cell transplantation for high-risk ALL
    C Linker
    L Damon
    T Martin
    K Blume
    S Forman
    D Snyder
    J Wolf
    R Negrin
    [J]. Bone Marrow Transplantation, 2011, 46 : 460 - 461
  • [8] Lenalidomide Maintenance for High-Risk Multiple Myeloma after Allogeneic Hematopoietic Cell Transplantation
    Alsina, Melissa
    Becker, Pamela S.
    Zhong, Xiaobo
    Adams, Alexia
    Hari, Parameswaran
    Rowley, Scott
    Stadtmauer, Edward A.
    Vesole, David H.
    Logan, Brent
    Weisdorf, Daniel
    Qazilbash, Muzaffar
    Popplewell, Leslie L.
    McClune, Brian
    Bensinger, William
    Riches, Marcie
    Giralt, Sergio A.
    Pasquini, Marcelo C.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (08) : 1183 - 1189
  • [9] Lenalidomide: Based maintenance after autologous hematopoietic stem cell transplant for patients with high-risk multiple myeloma.
    Pasvolsky, Oren
    Milton, Denai R.
    Rauf, Mikael
    Tanner, Mark R.
    Bashir, Qaiser
    Srour, Samer Ali
    Saini, Neeraj
    Ramdial, Jeremy L.
    Nieto, Yago
    Lee, Hans C.
    Patel, Krina K.
    Kebriaei, Partow
    Thomas, Sheeba K.
    Weber, Donna M.
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [10] The Impact of Autologous Stem Cell Transplantation on the Genetics of High-Risk Relapsed Multiple Myeloma
    Shahin, Mohamed
    Pawlyn, Charlotte
    Weinhold, Niels
    Ashby, Timothy Cody
    Walker, Brian A.
    Wardell, Christopher P.
    Cairns, David
    Menzies, Tom
    Gregory, Walter Martin
    Kaiser, Martin F.
    Cook, Gordon
    Drayson, Mark T.
    Owen, Roger G.
    Jackson, Graham
    Davies, Faith E.
    Morgan, Gareth J.
    Jones, John R.
    [J]. BLOOD, 2022, 140 : 4232 - 4233
12345